- CELG has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $645.9 million.
- CELG traded 10,203 shares today in the pre-market hours as of 8:21 AM.
- CELG is up 3% today from yesterday's close.
EXCLUSIVE OFFER: Get the inside scoop on opportunities in CELG with the Ticky from Trade-Ideas. See the FREE profile for CELG NOW at Trade-Ideas More details on CELG: Celgene Corporation, a biopharmaceutical company, discovers, develops, and commercializes therapies to treat cancer and immune-inflammatory related diseases in the United States and internationally. CELG has a PE ratio of 57.6. Currently there are 17 analysts that rate Celgene a buy, no analysts rate it a sell, and 2 rate it a hold. The average volume for Celgene has been 5.1 million shares per day over the past 30 days. Celgene has a market cap of $87.9 billion and is part of the health care sector and drugs industry. The stock has a beta of 2.00 and a short float of 1.4% with 2.07 days to cover. Shares are up 33.5% year-to-date as of the close of trading on Wednesday. STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.